Acrivon Therapeutics, Inc. Common Stock
ACRV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18 | -$21 | -$20 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4 | $4 | $4 |
| Change in WC | $1 | $0 | -$4 | $2 |
| Other Non-Cash | $4 | $0 | -$0 | -$1 |
| Operating Cash Flow | -$12 | -$17 | -$20 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$0 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$33 | -$15 | -$20 | -$35 |
| Inv. Sales/Matur. | $40 | $35 | $40 | $50 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $6 | $19 | $19 | $14 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | -$1 |
| Financing Cash Flow | -$0 | -$0 | -$0 | -$1 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | $3 | -$1 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42 | $39 | $40 | $44 |
| End Cash | $35 | $42 | $39 | $40 |
| Free Cash Flow | -$13 | -$17 | -$20 | -$18 |